AI-generated summary
The authors studied Alzheimer's disease model mice exposed to continuous 808 nm light (photobiomodulation), 40 Hz pulsed visible light, or 40 Hz pulsed 808 nm light. They report fewer amyloid-beta plaques in treated brain slices and better Morris water maze performance than untreated mice, with cerebral amyloid angiopathy changing differently by treatment type.
- Who or what was studied
- Alzheimer's disease mouse model
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes an animal study and does not state group sizes or a control-group design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Phototherapy, Photon. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.